Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2018

Open Access 01-12-2018 | Research article

A survey of subjective constipation in Parkinson’s disease patients in shanghai and literature review

Authors: Jing Gan, Ying Wan, Junjie Shi, Mingzhu Zhou, Zhiyin Lou, Zhenguo Liu

Published in: BMC Neurology | Issue 1/2018

Login to get access

Abstract

Background

Constipation is one of the most frequent non-motor symptoms (NMS) in Parkinson’s disease (PD) and the prevalence of constipation in PD patients varies among different studies. We designed this study to survey the prevalence and clinical characteristics of subjective constipation and the appearance chronology between the emergence of constipation and onset of motor symptoms in PD patients from Shanghai, China.

Methods

268 PD patients were continuously recruited into this study. Parkinson’s related clinical information of the participants was collected. A spectrum of motor and nonmotor features was assessed with scales and questionnaires. Subjective constipation was defined by ROME III criteria.

Results

54.10% PD patients suffer from constipation. Among them, there was 47.59% having constipation before onset of motor symptoms. Compared with patients without constipation, patients with constipation reported lower daily water intake and less exercise, and were dominated by bradykinetic-rigid motor phenotype at onset and were prone to have anxiety, depression and insomnia. The time span between constipation and the onset of motor symptoms was (6.62 ± 9.32) years. Constipation occurred more frequently between 2 and 10 years before onset of motor symptoms. Patients suffering with constipation were then divided into two groups according to the time sequence of constipation and motor onset: ‘constipation pre-motor sign’ group and ‘constipation post-motor sign’ group. Total timespan from earliest initial symptoms to present was similar. Compared with ‘constipation post-motor sign’ group, the patients in ‘constipation pre-motor sign’ group experienced an older motor symptoms onset age, less serious motor symptoms, more serious constipation and less daily levodopa dosage.

Conclusions

Our results supported that constipation could be a pre-motor symptom of PD. Different clinical characteristics were found in different constipation-loading time relative to motor symptoms. Research of constipation may be useful to better understand the early stages of PD and assessment of constipation with validated criteria may have utility as a risk factor for predicting PD in the prodromal phase.
Literature
1.
Knudsen K, Krogh K, Østergaard K, Borghammer P. Constipation in Parkinson’s disease: subjective symptoms, objective markers and new perspectives. Mov Disord. 2017;32(1):94–105.CrossRefPubMed
2.
Stirpe P, Hoffman M, Badiali D, Colosimo C. Constipation: an emerging risk factor for Parkinson’s disease? Eur J Neurol. 2016;23:1606–13.CrossRefPubMed
3.
Fasano A, Visanji NP, Liu LWC, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol. 2015;14:625–39.CrossRefPubMed
4.
Chen H, Zhao EJ, Zhang W, Lu Y, Liu R, Huang X, et al. Meta-analyses on prevalence of selected Parkinson's nonmotor symptoms before and after diagnosis. Transl Neurodegener. 2015;4(1):1.CrossRefPubMedPubMedCentral
5.
Gan J, Zhou M, Chen W, Liu ZG. Non-motor symptoms in Chinese Parkinson's disease patients. J Clin Neurosci. 2014;21(5):751–4.CrossRefPubMed
6.
Asams-Carr KL, Bestwick JP, Shribman S, Lees A, Schrag A, Noyce AJ. Constipation preceding Parkinson’s disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2016;87:710–6.CrossRef
7.
Postuma RB, Gagnon JF, Pelletier A, Montplaisir J. Prodomal autonomic symptoms and signs in Parkinson’s disease and dementia with Lewy bodies. Mov Disord. 2013;28:597–604.CrossRefPubMed
8.
Hughes AJ, Daniel SE, Lees AJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson’s disease. Am Acad Neurol. 2001;57:1497–9.
9.
Rome Foundation. Guideline-Rome III diagnostic criteria for functional gastrointestinal disorders. J Gastrointestin Liver Dis. 2006;15:307–12.
10.
Agachan F, Chen T, Pfeifer J, Reissman P, Wexner SD. A constipation scoring system to simplify evaluation and management of constipated patients. Dis Colon rectum. 1996;39(6):681–5.CrossRefPubMed
11.
Knudsen K, Fedorova TD, Bekker AC, Iversen P, Østergaard K, Krogh K et al. Objective colonic dysfunction id far more prevalent than subjective constipation in Parkinson’s disease: a colon transit and volume study. J Parkinsons Dis 2017 Jan 30. https://​doi.​org/​10.​3233/​JPD-161050. [Epub ahead of print].
12.
Chinese Nutrition Society. The dietary guidelines for Chinese residents (2007). Acta Nutrimenta Sinica. 2008;30(1):2–18.
13.
Lindberg G, Hamid SS, Malfertheiner P, Thomsen OO, Fernandez LB, Garisch J, et al. World gastroenterology organisation global guideline:Constipation a global perspective. J Clin Gastroenterol. 2011;45:483–7.CrossRefPubMed
14.
Barichella M, Cereda E, Cassani E, Frazzitta G, Pezzoli G. A focus on Rome III criteria for the assessment of constipation in Parkinson’s disease. Mov Disord. 2017;32(4):630.CrossRefPubMed
15.
Barichella M, Cereda E, Madio C, Iorio L, Pusani C, Cancello R, et al. Nutritional risk and gastrointestinal dysautonomia symptoms in Parkinson’s disease outpatients hospitalized on a scheduled basis. Br J Nutr. 2013;110(2):347–53.CrossRefPubMed
16.
Cassani E, Barichella M, Cancello R, Cavanna F, Iorio L, Cereda E, et al. Increased urinary indoxyl sulfate (indican): new insights into gut dysbiosis in Parkinson’s disease. Parkinsonism Relat Disord. 2015;21(4):389–93.CrossRefPubMed
17.
Barichella M, Cereda E, Cassani E, Pinelli G, Iorio L, Ferri V, et al. Dietary habits and neurological features of Parkinson’s disease patients: implications for practice. Clin Nutr. 2016 Jul;5(16):30155–8.
18.
Kaye J, Gage H, Kimber A, Storey L, Trend P. Excess burden of constipation in Parkinson’s disease: a pilot study. Mov Disord. 2006;21:1270–3.CrossRefPubMed
19.
Pont-Sunyer C, Hotter A, Caig C, Seppi K, Compta Y, Katzenschlager R, et al. The onset of nonmotor symptoms in Parkinson’s disease (the ONSET PD study). Mov Disord. 2014;30:1–9.
20.
Cersosimo MG, Raina GB, Pecci C, Pellene A, Calandra CR, Gutiérrez C, et al. Gastrointestinal manifestations in Parkinson’s disease: prevalence and occurrence before motor symptoms. J Neurol. 2013;260:1332–8.CrossRefPubMed
21.
Rodrihuez-Violante M, de Saráchaga AJ, Cervantes-Arriaga A, Millán-Cepeda R, Leal-Ortega R, Estrada-Bellmann I, et al. Self-perceived pre-motor symptoms load in patients with Parkinson’s disease: a retrospective study. J Parkinsons Dis. 2016;6(1):183–90.CrossRef
22.
Schrag A, Horsfall L, Walters K, Noyce A, Petersen I. Prediagnostic presentations of Parkinson’s disease in primary care: a case-control study. Lancet Neurol. 2015;14:57–64.CrossRefPubMed
23.
Ueki A, Otsuka M. Life style risks of Parkinson's disease: association between decreased water intake and constipation. J Neurol. 2004;251(Suppl 7):vII18–23.PubMed
24.
Borovac JA. Side effects of a dopamine agonist therapy for Parkinson’s disease: a mini-review of clinical pharmacology. Yale J Biol Med. 2016;89:37–47.PubMedPubMedCentral
25.
Savica R, Carlin JM, Grossardt BR, Bower JH, Ahlskog JE, Maraganore DM, et al. Medical records documentation of constipation preceding Parkinson disease. A case-control study. Neurology. 2009;73:1752–8.CrossRefPubMedPubMedCentral
26.
Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24:197–211.CrossRefPubMed
27.
Del Tredici K, Hawkes CH, Ghebremedhin E, Braak H. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease. Acta Neuropathol. 2010;119:703–13.CrossRefPubMed
28.
Arnhold M, Dening Y, Chopin M, Arevalo E, Schwarz M, Reichmann H, et al. Changes in the sympathetic innervations of the gut in rotenone treated mice aas possible early biomarker for Parkinson’s disease. Clin Auton Res. 2016;26:211–22.CrossRefPubMedPubMedCentral
29.
Mahlknecht P, Seppi K, Poewe W. The concept of prodromal Parkinson’s disease. J Parkinson Dis. 2015;5:681–97.CrossRef
Metadata
Title
A survey of subjective constipation in Parkinson’s disease patients in shanghai and literature review
Authors
Jing Gan
Ying Wan
Junjie Shi
Mingzhu Zhou
Zhiyin Lou
Zhenguo Liu
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2018
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-018-1034-3

Other articles of this Issue 1/2018

BMC Neurology 1/2018 Go to the issue

Correction

Correction to: Case series of Creutzfeldt-Jakob disease in a third-level hospital in Quito

Research article

Feasibility trial of an early therapy in perinatal stroke (eTIPS)

Research article

Computer-assisted rehabilitation of attention in pediatric multiple sclerosis and ADHD patients: a pilot trial

Research article

LARGE expression in different types of muscular dystrophies other than dystroglycanopathy

Study protocol

Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus

Research article

Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study